Screening and identification of plasma lncRNAs uc.48+ and NR_105053 as potential novel biomarkers for cured pulmonary tuberculosis
In 2018, there were about 10 million new tuberculosis (TB) cases and 1.24 million TB deaths worldwide. China is ranked second for TB disease burden in the world with estimated 866,000 new TB patients and 37,000 TB related deaths annually (World Health Organization, 2019). One of the reasons for the high incidence of TB is the early discharge of uncured patients who can cause disease transmission. At present, cured TB is mainly evaluated by the following standards: ① Whether the patient has received standardized anti-TB treatment; ② Chest X-ray and/or CT scan results; ③ Sputum smear and sputum culture results.
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Zhi-Bin Li, Yu-Shuai Han, Li-Liang Wei, Li-Ying Shi, Wen-Jing Yi, Jing Chen, Huai Huang, Ting-Ting Jiang, Ji-Cheng Li Source Type: research
More News: China Health | CT Scan | Infectious Diseases | International Medicine & Public Health | Papanicolaou (Pap) Smear | PET Scan | Tuberculosis | WHO